Citation: | ZHANG Yao, ZHAO Chengjun, REN Bin, DU Lei, MA Qianyuan. Research Progress on Prognostic Prediction Models After Radical Resection of Hepatocellular Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1266-1273. DOI: 10.12290/xhyxzz.2023-0235 |
[1] |
Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2018, 391: 1301-1314. DOI: 10.1016/S0140-6736(18)30010-2
|
[2] |
Villanueva A. Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380: 1450-1462. DOI: 10.1056/NEJMra1713263
|
[3] |
Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China[J]. Hepatology, 2014, 60: 2099-2108. DOI: 10.1002/hep.27406
|
[4] |
沈英皓, 孙惠川, 周俭. 肝切除术前肝脏储备功能评估[J]. 中华肝脏外科手术学电子杂志, 2019, 8: 469-472. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHZW201906001.htm
|
[5] |
Yu DC, Chen WB, Jiang CP, et al. Risk assessment in patients undergoing liver resection[J]. Hepatobiliary Pancreat Dis Int, 2013, 12: 473-479. DOI: 10.1016/S1499-3872(13)60075-2
|
[6] |
Byrd K, Alqahtani S, Yopp AC, et al. Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma[J]. Semin Liver Dis, 2021, 41: 1-8. DOI: 10.1055/s-0040-1719178
|
[7] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版)[J]. 中华肝脏病杂志, 2022, 30: 367-388. https://www.cnki.com.cn/Article/CJFDTOTAL-XIBU202304002.htm
|
[8] |
Zhou SJ, Zhang EL, Liang BY, et al. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis[J]. J Surg Res, 2016, 200: 444-451. DOI: 10.1016/j.jss.2015.08.027
|
[9] |
Watanabe Y, Aikawa M, Kato T, et al. Influence of Child-Pugh B7 and B8/9 cirrhosis on laparoscopic liver resection for hepatocellular carcinoma: a retrospective cohort study[J]. Surg Endosc, 2023, 37: 1316-1333. DOI: 10.1007/s00464-022-09677-x
|
[10] |
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD[J]. J Hepatol, 2005, 42: S100-S107. DOI: 10.1016/j.jhep.2004.11.015
|
[11] |
Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31: 864-871. DOI: 10.1053/he.2000.5852
|
[12] |
Badawy A, Seo S, Toda R, et al. Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best[J]. ANZ J Surg, 2019, 89: 1275-1280. DOI: 10.1111/ans.15368
|
[13] |
Wang YY, Zhao XH, Ma L, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118: 440-445. DOI: 10.1002/jso.25184
|
[14] |
陈敏强, 李文韬, 刘晓光, 等. 新型肝功能评分模型在肝细胞癌射频消融治疗中的应用价值[J]. 临床肝胆病杂志, 2020, 36: 2092-2096.
|
[15] |
Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33: 550-558.
|
[16] |
Fagenson AM, Gleeson EM, Pitt HA, et al. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes[J]. J Am Coll Surg, 2020, 230: 637-645. DOI: 10.1016/j.jamcollsurg.2019.12.007
|
[17] |
Lin CY, Lin CC, Wang CC, et al. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection[J]. World J Surg, 2020, 44: 247-257. DOI: 10.1007/s00268-019-05197-3
|
[18] |
Marasco G, Alemanni LV, Colecchia A, et al. Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2021, 10: 2011. DOI: 10.3390/jcm10092011
|
[19] |
Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma[J]. Br J Surg, 2016, 103: 725-734. DOI: 10.1002/bjs.10095
|
[20] |
Lau W, Leung K, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice[J]. Ann Surg, 1997, 225: 281-285. DOI: 10.1097/00000658-199703000-00007
|
[21] |
Roayaie S, Jibara G, Berhane S, et al. PALBI An objective score based on platelets, albumin bilirubin stratifies HCC patients undergoing resection & ablation better than child's classification[J]. Hepatology, 2015, 62: 624A-690A. DOI: 10.1002/hep.28219
|
[22] |
Lu LH, Zhang YF, Cai MY, et al. Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma[J]. Dig Liver Dis, 2019, 51: 1430-1437. DOI: 10.1016/j.dld.2019.04.006
|
[23] |
Luo HM, Zhao SZ, Li C, et al. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study[J]. Medicine (Baltimore), 2018, 97: e0226. DOI: 10.1097/MD.0000000000010226
|
[24] |
Shehta A, Han HS, Ahn S, et al. Post-resection recurrence of hepatocellular carcinoma in cirrhotic patients: Is thrombocytopenia a risk factor for recurrence[J]. Surg Oncol, 2016, 25: 364-369. DOI: 10.1016/j.suronc.2016.08.002
|
[25] |
Maithel SK, Kneuertz PJ, Kooby DA, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analy-sis[J]. J Am Coll Surg, 2011, 212: 638-650. DOI: 10.1016/j.jamcollsurg.2011.01.004
|
[26] |
Wang ZX, Peng W, Zhang XY, et al. Prognostic signifi-cance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy[J]. Medicine (Baltimore), 2021, 100: e24476. DOI: 10.1097/MD.0000000000024476
|
[27] |
Omichi C, Nakamura K, Haraga J, et al. Glasgow prog-nostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer[J]. Cancer Med, 2016, 5: 1074-1080. DOI: 10.1002/cam4.681
|
[28] |
Kumamoto T, Takeda K, Matsuyama R, et al. Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy[J]. Anticancer Res, 2023, 43: 875-882. DOI: 10.21873/anticanres.16230
|
[29] |
Kaibori M, Hiraoka A, Iida H, et al. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan[J]. Cancers (Basel), 2022, 14: 2091. DOI: 10.3390/cancers14092091
|
[30] |
Chang KV, Chen JD, Wu WT, et al. Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis[J]. Liver Cancer, 2018, 7: 90-103. DOI: 10.1159/000484950
|
[31] |
Liu PH, Hsu CY, Hsia CY, et al. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era[J]. J Gastroenterol Hepatol, 2017, 32: 879-886. DOI: 10.1111/jgh.13608
|
[32] |
Sonohara F, Yamada S, Tanaka N, et al. Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma[J]. Hepatol Res, 2019, 49: 1305-1315. DOI: 10.1111/hepr.13400
|
[33] |
Jaruvongvanich V, Sempokuya T, Linda W, et al. Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?[J]. J Gastroin-test Oncol, 2018, 9: 750-761. DOI: 10.21037/jgo.2018.05.11
|
[34] |
Liao Y, Wei R, Yao RZ, et al. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study[J]. BMC Surg, 2021, 21: 72. DOI: 10.1186/s12893-020-01037-7
|
[35] |
Zhang J, Luo Y, Li C, et al. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection[J]. Biosci Trends, 2019, 13: 351-357. DOI: 10.5582/bst.2019.01212
|
[36] |
Liao R, Li DW, Du CY, et al. combined preoperative ALBI and FIB-4 is associated with recurrence of hepatocellular carcinoma after curative hepatectomy[J]. J Gastrointest Surg, 2018, 22: 1679-1687. DOI: 10.1007/s11605-018-3810-1
|
[37] |
Luo H, Li C, Chen LP, et al. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection[J]. Biosci Trends, 2019, 13: 176-181. DOI: 10.5582/bst.2019.01088
|
[38] |
Pereyra D, Rumpf B, Ammann M, et al. The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy[J]. Ann Surg Oncol, 2019, 26: 791-799. DOI: 10.1245/s10434-018-07125-6
|
[39] |
Kaibori M, Hiraoka A, Matsui K, et al. Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases[J]. Cancers (Basel), 2022, 14: 1402. DOI: 10.3390/cancers14061402
|
[40] |
Bray F, Ferlay J, Soerjomataram L, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2020, 70: 313.
|
[41] |
Wang Q, Su B, Dong LW, et al. Liquid Chromatography-Mass Spectrometry-Based Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection[J]. J Proteome Res, 2020, 19: 3533-3541. DOI: 10.1021/acs.jproteome.0c00344
|
[42] |
Fang C, Su B, Jiang TY, et al. Prognosis prediction of hepatocellular carcinoma after surgical resection based on serum metabolic profiling from gas chromatography-mass spectrometry[J]. Anal Bioanal Chem, 2021, 413: 3153-3165. DOI: 10.1007/s00216-021-03281-z
|
[43] |
Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14: 527-539. DOI: 10.1038/nrgastro.2017.72
|
[44] |
He Y, Liang T, Chen Z, et al. Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model[J]. Oxid Med Cell Longev, 2022, 2022: 7261786.
|
[45] |
Saillard C, Schmauch B, Laifa O, et al. Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides[J]. Hepatology, 2020, 72: 2000-2013. DOI: 10.1002/hep.31207
|
[46] |
Wong GL, Hui VW, Tan QX, et al. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis[J]. JHEP Rep, 2022, 4: 100441. DOI: 10.1016/j.jhepr.2022.100441
|
[1] | CHEN Zijia, PENG Wenxi, ZHANG Dezheng, LIU Xin, WANG Zhifei. Application, Challenges, and Prospects of Large Language Model in the Field of Traditional Chinese Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 83-89. DOI: 10.12290/xhyxzz.2024-0315 |
[2] | FAN Wanli, HE Dong, ZHANG Shuze, CHEN Gang, ZHAO Bin, CHENG Zhibin. Predictive Value of Albumin-Bilirubin Score Combined with Liver Function Index and CEA for Liver Metastasis of Colorectal Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 99-108. DOI: 10.12290/xhyxzz.2023-0261 |
[3] | OUYANG Jing, CHANG Hong, YANG Mengjiao, ZHANG Meng, TIAN Meng, ZHENG Ya, WANG Yuping, CHEN Zhaofeng. Establishment and Validation of A Prediction Model for the Occurrence of Acute Kidney Disease in Patients with Liver Cirrhosis[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 89-98. DOI: 10.12290/xhyxzz.2023-0394 |
[4] | HUANG Lu, WU Youbin, NI Yiran, LIU Mengyuan, WU Jiangfeng, ZHANG Yanqiong. The Mechanism of miRNAs in Liver Fibrosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1251-1257. DOI: 10.12290/xhyxzz.2023-0125 |
[5] | ZHANG Nan, LIN Qingting, ZHU Huadong. Prediction Model for In-hospital Death of Patients with Cardiac Arrest[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1023-1030. DOI: 10.12290/xhyxzz.2023-0378 |
[6] | YANG Wenlei, LIU Fangfang, XU Ruiping, YANG Wei, HE Yu, LIU Zhen, ZHOU Fuyou, HENG Fanxiu, HOU Bolin, ZHANG Lixin, CHEN Lei, ZHANG Fan, CAI Fen, XU Huawen, LIN Miaoping, LIU Mengfei, PAN Yaqi, LIU Ying, HU Zhe, CHEN Huanyu, HE Zhonghu, KE Yang. Development and Validation of A Prognosis Prediction Model for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy: A Multicenter Real-world Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 101-113. DOI: 10.12290/xhyxzz.2022-0496 |
[7] | DAI Liyuan, SHI Yuankai, HAN Xiaohong. Advances in Dynamic Monitoring of Immune Checkpoint Inhibitors as the Prognostic Markers for Advanced Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 287-295. DOI: 10.12290/xhyxzz.2021-0608 |
[8] | Cheng XUE, Chen-chen ZHOU, Chang-lin MEI. Prognostic Evaluation and Treatment of Autosomal Dominant Polycystic Kidney Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 75-80. DOI: 10.3969/j.issn.1674-9081.2018.01.014 |
[9] | Bin ZHOU, Ling XIN, Yuan-jia CHENG, Qian LIU, Ling XU, Jing-ming YE, Xue-ning DUAN, Yin-hua LIU. Critical Updates and Clinical Significance of the 8th Edition of AJCC Breast Cancer Prognostic Staging System[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 235-238. DOI: 10.3969/j.issn.1674-9081.2017.05.008 |
[10] | Ming-yang LIU, Jie CHEN, Jian GUAN. Local Injections of Cholesterol-conjugated let-7a Mimics Inhibit Tumor Growth and Metastasis of Hepatocellular Carcinoma in a Subcutaneous Xenograft Nude Mouse Model by Targeting K-Ras, H-Ras, and N-Ras[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(2): 133-139. DOI: 10.3969/j.issn.1674-9081.2015.02.012 |